
    
      The patients will be randomly assigned into one of the two groups to receive either
      bupivacaine hydrochloride 0.5% solution if they are randomized to the treatment group or 0.9%
      NaCl solution if they are randomized to the control group. These solutions will be poured
      into the retropharyngeal space intraoperatively before wound closure.
    
  